Cryoport Stock News

B. Riley restated their buy rating on shares of Cryoport (NASDAQ:CYRX) in a research report report published on Thursday morning, AnalystRatings.com reports. Other analysts also recently issued reports about the company. KeyCorp raised their target price on Cryoport from $75.00 to $92.00 and gave the company an overweight rating in a research note on Friday, []

California State Teachers Retirement System decreased its position in Cryoport, Inc. (NASDAQ:CYRX) by 7.1% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 55,897 shares of the consumer goods makers stock after selling 4,295 shares during the period. California State Teachers Retirement System owned about []

Cryoport's (CYRX) CEO Jerrell Shelton on Q3 2021 Results - Earnings Call Transcript

CryoPort (NASDAQ:CYRX) reported its Q3 earnings results on Thursday, November 4, 2021 at 04:05 PM. Here's what investors need to know about the announcement.

Cryoport is enjoying extremely aggressive revenue increases. The recent quarter witnessed a near five-fold sales increase year over year. The company is enjoying substantial upsides from the industry

Cryoport looks well-positioned to benefit from macroeconomic crosscurrents that are driving value in biological logistics. The company is now supporting 69 Phase 3 clinical trials, evidencing a tide o

Cryoport Inc (NASDAQ: CYRX) and Mitsubishi Logistics Corporation (MLC) entered a multi-year strategic business alliance  to create an integrated regenerative medicine supply chain partnership in

NASHVILLE, Tenn., Aug. 25, 2021 /PRNewswire/ --  Cryoport, Inc.  (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative temperature-controlled supply chain solutions t

Cryoport, Inc. (CYRX) CEO Jerrell Shelton on Q2 2021 Results - Earnings Call Transcript

CryoPort, Inc. (CYRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cryoport (CYRX) has been struggling lately, but the selling pressure may be coming to an end soon.

The stock price of CryoPort (NASDAQ: CYRX), a provider of cold chain logistics solutions for biopharmaceutical companies, reached levels of $67 toward the end of June, reflecting a solid 42% gain this

NASHVILLE, Tenn., June 22, 2021 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in temperature-controlled supply chain solutions for the life sciences ind

NASHVILLE, Tenn., May 19, 2021 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indu

NASHVILLE, Tenn., May 18, 2021 /PRNewswire/ -- Cryoport, Inc.  (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative temperature-controlled supply chain solutions to t